SCHEMBL5816680

SCHEMBL5816680

ClCc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 5/20 0.73
PDE4D Q08499 1/20 0.73
GABRA1 P14867 5/20 0.45
GABRA5 P31644 5/20 0.45
GABRA2 P47869 5/20 0.45
GABRB2 P47870 5/20 0.45
HPGD P15428 3/20 0.45
GABRA3 P34903 3/20 0.45
BRD4 O60885 1/20 0.45
LMNA P02545 1/20 0.45
CNR1 P21554 1/20 0.45
PTAFR P25105 1/20 0.43
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
CACNA1F O60840 1/20 0.40
ALB P02768 1/20 0.40
GABRB1 P18505 1/20 0.40
AKR1C3 P42330 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11793386 0.86 OPRK1 (0.57) OPRK1PDE4DGABRA1GABRA5GABRA2
Estazolam SCHEMBL28766 0.84 OPRK1 (1.00) OPRK1PDE4DGABRA1GABRA5GABRA2
Estazolam SCHEMBL29357458 0.84 OPRK1 (1.00) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL11108528 0.82 OPRK1 (0.74) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL6060113 0.81 OPRK1 (0.72) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL7328162 0.80 OPRK1 (0.71) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL11016086 0.80 OPRK1 (0.70) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL11199716 0.79 OPRK1 (0.46) OPRK1PDE4DPTAFR
SCHEMBL11714001 0.78 OPRK1 (0.65) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL11116626 0.78 OPRK1 (0.67) OPRK1PDE4DGABRA1GABRA5GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0104053-A1 Benzodiazepines for treating panic disorders THE UPJOHN COMPANY (US) 1984-03-28 EP claimed
WO-2006036928-A2 INHIBITORS OF MATRIX METALLOPROTEINASES TO TREAT NEUROLOGICAL DISORDERS WAYNE STATE UNIVERSITY (US) 2006-04-06 WO disclosed
EP-0139460-A2 Benzodiazepines and their therapeutic use THE UPJOHN COMPANY (US) 1985-05-02 EP disclosed
EP-0104053-A1 Benzodiazepines for treating panic disorders THE UPJOHN COMPANY (US) 1984-03-28 EP disclosed